Cor Vasa 2015, 57(3):e187-e189 | DOI: 10.1016/j.crvasa.2015.01.003

An update of the expert consensus statement of the Czech Hypertension Society on renal denervation in resistant hypertension

Jan Filipovskýa,*, Václav Monhartb, Jiří Widimský jr.c
a II. interní klinika, Lékařská fakulta Plzeň, Univerzita Karlova v Praze a Fakultní nemocnice Plzeň, Plzeň, Česká republika
b Interní klinika, Univerzita Karlova v Praze, 1. lékařská fakulta a Ústřední vojenská nemocnice - Vojenská fakultní nemocnice, Praha; Synlab Czech s.r.o., Nefrologická ambulance Praha, Česká republika
c Centrum pro hypertenzi, III. interní klinika - klinika endokrinologie a metabolismu, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha, Česká republika

In the spring of 2012, the Czech Society of Cardiology and Czech Hypertension Society issued a joint expert consensus statement on catheter-based renal denervation (RDN) in the Czech Republic. On the basis of new information from the SYMPLICITY HTN-3, PRAGUE-15 and other studies, there is no reason to introduce RDN into clinical practice. New modalities for RDN, such as radiofrequency ablation, are investigated.

Keywords: Arterial hypertension; Consensus statement; Renal denervation

Received: November 22, 2014; Revised: January 16, 2015; Accepted: January 20, 2015; Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Filipovský J, Monhart V, Widimský J. An update of the expert consensus statement of the Czech Hypertension Society on renal denervation in resistant hypertension. Cor Vasa. 2015;57(3):e187-189. doi: 10.1016/j.crvasa.2015.01.003.
Download citation

References

  1. P. Widimský, J. Filipovský, J. Widimský Jr., et al., Expert consensus statement of the Czech Society of Cardiology and the Czech Society of Hypertension on catheter-based sympathetic renal denervation procedures (RDN) in the Czech Republic, Cor et Vasa 54 (2012) e113-e134. Go to original source...
  2. M.D. Esler, H. Krum, P.A. Sobotka, et al., Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial, Lancet 376 (2010) 1903-1909. Go to original source...
  3. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, et al., on behalf of the SYMPLICITY HTN-3 Investigators, A controlled trial of renal denervation for resistant hypertension, New England Journal of Medicine 370 (2014) 1393-1401. Go to original source... Go to PubMed...
  4. A. Persu, Y. Jin, M. Azizi, et al., on behalf of the European Network COordinating research on Renal Denervation (ENCOReD), Blood pressure changes after renal denervation at 10 European expert centers, Journal of Human Hypertension 28 (2013) 150-156. Go to original source... Go to PubMed...
  5. J. Rosa, P. Widimský, P. Toušek, et al., Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension. Six-month results from the Prague-15 Study, Hypertension 65 (2015) 407-413. Go to original source... Go to PubMed...
  6. F.E. Fadl Elmula, P. Hoffmann, A.C. Larstorp, et al., Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension, Hypertension 63 (2014) 991-999. Go to original source... Go to PubMed...
  7. M. Ezzahti, A. Moelker, E.C. Friesema, et al., Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension, Journal of Hypertension 32 (2014) 135-141. Go to original source... Go to PubMed...
  8. V. Papademetriou, C.P. Tsioufis, A. Sinhal, et al., Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system, Hypertension 64 (2014) 565-572. Go to original source... Go to PubMed...
  9. A. Persu, Y. Jin, M. Baelen, et al., on behalf of the European Network Coordinating research on REnal Denervation (ENCOReD) Consortium, Eligibility for renal denervation. Experience at 11 European Expert Centers, Hypertension 63 (2014) 1319-1325. Go to original source... Go to PubMed...
  10. J. Rosa, T. Zelinka, O. Petrák, et al., Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?, Journal of Human Hypertension (2014), http://dx.doi.org/10.1038/jhh.2014.3. Go to original source... Go to PubMed...
  11. C. Templin, M. Jaguszewski, J.R. Ghadri, et al., Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTHTM multielectrode renal denervation catheter, European Heart Journal 34 (2013) 2141-2148. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.